GlassScriptPhysician profile
Jennifer Griffiths
NPI 1942656053
$2,512.48
in general payments reported to CMS, 2019-2025
15 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $108 · 2022: $351 · 2023: $657 · 2024: $332 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,053.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $576.99 | 2022-2024 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $405.03 | 2025 | |
| Aurinia Pharma U.S., INC. | $252.15 | 2022-2024 | Lupkynis |
| Otsuka America Pharmaceutical, INC. | $211.48 | 2025 | Jynarque |
| Amgen INC. | $210.55 | 2020-2025 | Tavneos, Krystexxa |
| Nxstage Medical, INC. | $161.83 | 2020-2023 | Pureflow Sl, Nxstage System One |
| Calliditas Therapeutics US INC. | $146.52 | 2023 | Tarpeyo |
| Vantive US Healthcare LLC | $144.66 | 2025 | Renal - Pd |
| Ardelyx, INC. | $125.00 | 2024 | Xphozah 30 Mg |
| Akebia Therapeutics INC | $125.00 | 2025 | Vafseo |
| Alexion Pharmaceuticals, INC. | $41.30 | 2020 | |
| Horizon Therapeutics Plc | $40.50 | 2023 | Krystexxa |
| Ethicon US, LLC | $33.97 | 2025 | Stratafix, Ethicon, Vistaseal |
| Fresenius USA Marketing, INC. | $24.26 | 2023 | Velphoro |
| Glaxosmithkline, LLC. | $13.24 | 2023 | Trelegy Ellipta, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Griffiths listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.